Skip to content
lsd.com

Iowa

Psychedelic trials in Iowa

10 registered trials has a study site in Iowa, and 3 are recruiting now.

10
Trials with a site here
3
Recruiting
4
Facilities

Open now

Recruiting in this state

TrialStatusPhaseSubstanceSites
Ketamine Alcohol (in Treatment-Resistant Depression)NCT02122562 · Mark NiciuRecruitingPhase 2ketamine1
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator TrialNCT06405607 · University of IowaRecruitingPhase 2psilocybin, ketamine1
University of Iowa Interventional Psychiatry Service Patient RegistryNCT04480918 · Mark NiciuRecruitingN/Aketamine1

Facilities

Where the research happens in Iowa

FacilityCityTrials
University of Iowa Health CareIowa City3
MercyOne Des Moines Medical CenterDes Moines1
University of IowaIowa City1
University of Iowa, Carver College of MedicineIowa City1

Stay told

When a trial opens in Iowa

Research alerts

Get a notification when a trial for trials in Iowa starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a Iowa site

TrialStatusPhaseSubstanceSites
Ketamine Alcohol (in Treatment-Resistant Depression)NCT02122562 · Mark NiciuRecruitingPhase 2ketamine1
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator TrialNCT06405607 · University of IowaRecruitingPhase 2psilocybin, ketamine1
University of Iowa Interventional Psychiatry Service Patient RegistryNCT04480918 · Mark NiciuRecruitingN/Aketamine1
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency DepartmentNCT04266288 · MercyOne Des Moines Medical CenterCompletedPhase 4ketamine1
A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant DepressionNCT02422186 · Janssen Research & Development, LLCCompletedPhase 3ketamine69
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant DepressionNCT02497287 · Janssen Research & Development, LLCCompletedPhase 3ketamine109
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionNCT02782104 · Janssen Research & Development, LLCCompletedPhase 3ketamine173
Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use DisorderNCT05421065 · Peggy C NopoulosActive, not recruitingPhase 2psilocybin, ketamine1
A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for SuicideNCT02133001 · Janssen Research & Development, LLCCompletedPhase 2ketamine14
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for SuicideNCT03185819 · Janssen Research & Development, LLCCompletedPhase 2ketamine51

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states